Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 25 of 69 entries
View as:

Pharmacokinetic Study of Livalo® Fixed Combination Drug in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01406431 Org: User:
Start: 08/31/11 End: 10/31/12 Due: 10/31/13

To Evaluate the Safety and PK Characteristics in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06355349 Org: User:
Start: 04/28/23 End: 07/17/23 Due: 07/17/24

To Evaluate the Safety and Pharmacokinetic Interactions in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06378684 Org: User:
Start: 09/10/23 End: 01/13/24 Due: 01/13/25

Efficacy and Safety of CWP-0403 Compared to Sitagliptin in Patients With Type 2 Diabetes Mellitus Insufficiently Controlled With Metformin Alone

Phase: N/A Priority: Normal
NCT ID: NCT01529541 Org: User:
Start: 05/31/11 End: 10/31/13 Due: 10/31/14

To Evaluate the Safety and PK Characteristics After Co-administration of JW0104 and C2402 and Administration of JW0105

Phase: N/A Priority: Normal
NCT ID: NCT06754943 Org: User:
Start: 01/31/25 End: 04/30/25 Due: 04/30/26

Efficacy and Safety of Silodosin on Voiding Dysfunction Associated With Neurogenic Bladder

Phase: N/A Priority: Normal
NCT ID: NCT01228370 Org: User:
Start: 04/30/11 End: 01/31/12 Due: 01/31/13

To Evaluate the Pharmacokinetic Characteristics and Safety in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06361277 Org: User:
Start: 11/03/23 End: 11/27/23 Due: 11/27/24

A Safety, PK, PD and Food Effect Study of URC102 in Healthy Adults and Patients With Renal Impairment

Phase: N/A Priority: Normal
NCT ID: NCT05198778 Org: User:
Start: 11/29/21 End: 07/13/22 Due: 07/13/23

South Korean Pitavastatin Heart Failure Study

Phase: N/A Priority: Normal
NCT ID: NCT00701285 Org: User:
Start: 07/31/08 End: 05/31/14 Due: 05/31/15

A Trial to Evaluate the Effect of LEO 152020 on the Heart of Healthy People

Phase: N/A Priority: Normal
NCT ID: NCT05508776 Org: User:
Start: 09/16/22 End: 12/28/22 Due: 12/28/23

A Therapeutic Confirmatory Study of Epaminurad Versus Febuxostat in Gout Patients

Phase: N/A Priority: Normal
NCT ID: NCT05815901 Org: User:
Start: 03/14/23 End: 08/31/25 Due: 08/31/26

To Evaluate the Safety and PK Characteristics in Healthy Volunteers-JW24107

Phase: N/A Priority: Normal
NCT ID: NCT06816719 Org: User:
Start: 09/02/24 End: 11/12/24 Due: 11/12/25

Evaluate the Efficacy and Safety of Co-administration of JW0104+C2402 in Patients with Hypertension and Dyslipidemia

Phase: N/A Priority: Normal
NCT ID: NCT06643130 Org: User:
Start: 11/30/24 End: 04/30/26 Due: 04/30/27

Efficacy and Safety Study of Pitavastatin Versus Atorvastatin to Treat Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT01166633 Org: User:
Start: 06/30/09 End: 02/28/11 Due: 02/28/12

Study of Erythropoietin (EPO) Administration Schedule

Phase: N/A Priority: Normal
NCT ID: NCT01111630 Org: User:
Start: 10/31/09 End: 01/31/14 Due: 01/31/15

To Evaluate the Safety/Tolerability and Pharmacokinetic Characteristics in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06703710 Org: User:
Start: 01/06/25 End: 01/31/26 Due: 01/31/27

Pitavastatin Pre-Treatment Study in Patient With Elective PCI for Stable Angina Pectoris (PIPA)

Phase: N/A Priority: Normal
NCT ID: NCT00786734 Org: User:
Start: 08/31/08 End: 07/31/10 Due: 07/31/11

This Study is to Evaluate the Safety and Efficacy of Avanafil in the Treatment of Erectile Dysfunction.

Phase: N/A Priority: Normal
NCT ID: NCT01705197 Org: User:
Start: 02/29/12 End: 11/30/13 Due: 11/30/14

PK,PD and DDI of Epaminurad and Naproxen in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06435442 Org: User:
Start: 06/03/24 End: 09/30/25 Due: 09/30/26

To Evaluate the Efficacy and Safety in Patients With Primary Hypercholesterolemia

Phase: N/A Priority: Normal
NCT ID: NCT04584736 Org: User:
Start: 06/11/19 End: 10/12/20 Due: 10/12/21

Efficacy and Safety of Silodosin in the Treatment of Natural Expulsion in Patients With Ureteral Stones

Phase: N/A Priority: Normal
NCT ID: NCT01533389 Org: User:
Start: 10/31/11 End: 08/31/12 Due: 08/31/13

Therapeutic Confirmatory Study to Evaluate the Efficacy and Safety of Avanafil

Phase: N/A Priority: Normal
NCT ID: NCT00903981 Org: User:
Start: 03/31/09 End: 11/30/09 Due: 11/30/10

Phase 1 Study of URC102 in Healthy Subjects

Phase: N/A Priority: Normal
NCT ID: NCT01953497 Org: User:
Start: 05/23/13 End: 07/31/14 Due: 07/31/15

Efficacy and Safety Study of Iron Sucrose and Oral Iron Acetyl-transferrin Hydroglycerin

Phase: N/A Priority: Normal
NCT ID: NCT00802139 Org: User:
Start: 02/29/08 End: 10/31/10 Due: 10/31/11

Safety and Efficacy Study of Pitavastatin in Patient With a Metabolic Syndrome

Phase: N/A Priority: Normal
NCT ID: NCT00640276 Org: User:
Start: 04/30/08 End: 06/30/11 Due: 06/30/12